NVO News

Recent headlines mentioning NVO, newest first.

NVO neutral

Can Oral Wegovy Help Novo Nordisk Capture China’s $4.46 Billion GLP-1 Opportunity?

insidermonkey.com·Sep 9, 2026·Novo Nordisk A/S (NYSE:NVO) has moved one step closer to bringing its oral Wegovy treatment to China after the country’s drug regulator accepted the company?...
NVO bullish

Wegovy’s Latest Trial Gives Novo Nordisk (NVO) Another Potential Growth Catalyst

insidermonkey.com·Sep 7, 2026·Novo Nordisk A/S (NYSE:NVO) has delivered encouraging late-stage data for Wegovy in younger children, with its STEP Young trial showing that 40.4% of children a...
NVO neutral

Futures Drop As Iran Hostilities Send Brent To 6 Week High Above $97

zerohedge.com·Sep 7, 2026·US stock futures slipped in cautious, low volume trading as the latest Middle East escalation pushed oil prices higher, lifting bond yields in Europe and Asia. ...
NVO neutral

Novo Nordisk A/S - share repurchase programme

manilatimes.net·Sep 7, 2026·Bagsværd, Denmark, 07 September 2026 - On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/201...
NVO bearish

SA’s R3bn weight-loss drug boom: treatment, opportunity or a new divide?

biznews.com·Sep 4, 2026·Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark Photographer: Carsten Snejbjerg/Bloomberg Health SA’s R3bn weight...
NVO bearish

Wegovy’s German Debut Opens a New Front for Novo Nordisk (NVO)

insidermonkey.com·Sep 3, 2026·Novo Nordisk A/S (NYSE:NVO) has launched its Wegovy weight-loss pill in Germany, making it the first country in the European Union where the oral version of the...
NVO neutral

Novo Nordisk A/S - share repurchase programme

manilatimes.net·Aug 31, 2026·Bagsværd, Denmark, 31 August 2026 - On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 o...
NVO bearish

Novo Nordisk: Why The Price Remains Stubbornly Low (Rating Downgrade) (NYSE:NVO)

seekingalpha.com·Aug 31, 2026·Ozempic manufacturer Novo Nordisk A/S ( NVO ) has dropped by over 9% since I last checked on the stock in July. There are very good reasons for this, which have...
NVO neutral

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine

fortune.com·Aug 29, 2026·Drugmakers found a promising cure for the obesity epidemic and their stocks were rewarded for it. Now, investors are salivating over a new crop of companies tac...
NVO bullish

Multiple System Atrophy Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

manilatimes.net·Aug 26, 2026·The multiple system atrophy clinical trial analysis report delivers important insights into ongoing research of 24+ pipeline multiple system atrophy drugs, clin...
NVO neutral

Eli Lilly (LLY) Is Suing Six Companies Over an Unapproved Drug—Leaving Novo Nordisk (NVO) Clear in the GLP-1 Wars

insidermonkey.com·Aug 24, 2026·On August 12, 2026, Eli Lilly and Company (NYSE:LLY) said that it filed six lawsuits against US companies it accuses of illegally selling black-market versions ...
NVO bearish

Is the Weight-Loss Drug Market Really a Winner-Take-All Fight Between Novo Nordisk (NVO) and Eli Lilly (LLY)?

insidermonkey.com·Aug 24, 2026·On August 13, 2026, Novo Nordisk A/S (NYSE:NVO) CEO Mike Doustdar told Reuters that investors are underestimating how much the obesity drug market will fragment...
NVO neutral

Novo Nordisk A/S - share repurchase programme

manilatimes.net·Aug 24, 2026·Bagsværd, Denmark, 24 August 2026 - On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 o...
NVO neutral

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851

manilatimes.net·Aug 24, 2026·LX9851 is a first-in-class, oral non-incretin candidate being developed by Novo Nordisk for the treatment of obesity and associated metabolic disorders Lexicon...
NVO bullish

Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?

insidermonkey.com·Aug 23, 2026·Novo Nordisk A/S (NYSE:NVO) has entered a strategic partnership with Amazon Web Services to accelerate drug discovery and modernize its operations through artif...
NVO bullish

Novo Nordisk: The Best Value In Pharma (NYSE:NVO)

seekingalpha.com·Aug 19, 2026·It has been quite a while since I last covered Novo Nordisk A/S ( NVO ) with a Strong Buy rating based on how cheap the valuation has become. It initially ralli...
NVO bearish

Novo Nordisk tests lower Wegovy pill doses in new weight-loss study

thehindubusinessline.com·Aug 19, 2026·Novo Nordisk A/S is testing small doses of its blockbuster Wegovy pill in a new study that will help establish how low patients can go in their dose and still l...
NVO neutral

A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.

financialpost.com·Aug 18, 2026·Article content NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – For as long as aesthetic medicine has existed, its central prom...
NVO bearish

Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start

finance.yahoo.com·Aug 17, 2026·On August 10, Eli Lilly and Company (NYSE:LLY)'s weight-loss pill Foundayo won approval in the UK, becoming the first country in Europe to clear the drug for bo...
NVO bearish

Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start

insidermonkey.com·Aug 17, 2026·On August 10, Eli Lilly and Company (NYSE:LLY)’s weight-loss pill Foundayo won approval in the UK, becoming the first country in Europe to clear the drug for ...
NVO bearish

Eli Lilly’s Weight-Loss Pill Just Got Its First Foothold in Europe

insidermonkey.com·Aug 15, 2026·Eli Lilly and Company (NYSE:LLY) cleared a notable regulatory hurdle on August 10, when Britain’s drug regulator authorized the company’s oral GLP-1 drug or...
NVO bullish

Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks?

insidermonkey.com·Aug 15, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
NVO bearish

Lilly escalates its fight against black market weight-loss shots

fortune.com·Aug 12, 2026·Eli Lilly & Co. is stepping up its fight against a booming black market for retatrutide, an experimental drug that the company is counting on to expand its cruc...
NVO neutral

The Market Is (Still) Underestimating Novo Nordisk (NYSE:NVO)

seekingalpha.com·Aug 12, 2026·In mid‑June 2026 I published my last article about Novo Nordisk A/S ( NVO ). In the article, I argued that the company is able to strike back, and I made a ve...
NVO bearish

Eli Lilly escalates fight against black market weight-loss medicines

thehindubusinessline.com·Aug 12, 2026·Eli Lilly & Co. is stepping up its fight against a booming black market for retatrutide, an experimental drug that the company is counting on to expand its cruc...
NVO bearish

Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

finance.yahoo.com·Aug 11, 2026·The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO) f...
NVO neutral

Novo Nordisk A/S Q2 Earnings Call Highlights

finance.yahoo.com·Aug 8, 2026·Millar said the product has captured about 90% of the U.S. oral obesity-medication market despite competition entering in early April. Roughly 80% of patients u...
NVO bullish

Futures Rise Ahead Of Closely Watched Jobs Report

zerohedge.com·Aug 7, 2026·US futures grind higher in a European session devoid of newsflow ahead of nonfarm payrolls. As of 815am ET, S&P futures rose 0.2% while Nasdaq futures gained 0....
NVO bullish

Novo Nordisk: The Market Has Lost Its Mind, Too Cheap To Ignore (NYSE:NVO)

seekingalpha.com·Aug 6, 2026·Novo Nordisk A/S ( NVO ) reported its second quarter earnings results this week. The company outperformed expectations and saw an improved growth rate compared ...
NVO neutral

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

manilatimes.net·Aug 6, 2026·Bagsværd, Denmark, 6 August 2026 - This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board memb...
NVO neutral

Novo Nordisk A/S 2026 Q2 - Results - Earnings Call Presentation (TSX:NOVO:CA) 2026-08-05

seekingalpha.com·Aug 5, 2026·To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from ...
NVO neutral

Novo Nordisk: Opportunistically Adding To A Long-Term Winner (Q2 Review) (NYSE:NVO)

seekingalpha.com·Aug 5, 2026·Novo Nordisk A/S ( NVO ) just reported its Q2 numbers , which came out a day early by the looks of it and surprised investors with what I thought were alright r...
NVO neutral

Novo Nordisk A/S - share repurchase programme

manilatimes.net·Aug 4, 2026·Bagsværd, Denmark, 4 August 2026 - On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of...
NVO neutral

Futures Rise As Oil Plunge Helps Yields Ease From Nosebleed Highs; All Eyes On Yentervention

zerohedge.com·Aug 3, 2026·Futures are higher with both tech and small caps outperforming as Trump points to a deal/advanded discussions with Iran (which Iran is naturally denying), which...
NVO neutral

Amgen Reports Theft of Patient Data in Cyber Incident

insurancejournal.com·Aug 3, 2026·Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing July 31...
NVO bullish

Pfizer Inc. (PFE) vs. Eli Lilly and Company (LLY): The Growth vs. Value Play in Pharma

insidermonkey.com·Jul 30, 2026·Pfizer (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) offer unique divergent investment opportunities in the pharmaceutical industry. While one acts as a value...
NVO bullish

Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight

manilatimes.net·Jul 28, 2026·The amylin analogs and combination therapies competitive landscape report delivers important insights into approved as well as ongoing research of 20+ pipeline ...
NVO neutral

GreensKeeper Value Fund Q2 2026 Letter

seekingalpha.com·Jul 27, 2026·Zhanna Hapanovich/iStock via Getty Images Value in Action After a very slow start to the year, the Value Fund surged +10.9% in Q2, bringing its year-to-date r...
NVO bullish

Jim Cramer Wants Novo Nordisk A/S (NYSE:NVO) To Compete With Eli Lilly In The Market & Not The Courts

insidermonkey.com·Jul 25, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
NVO bearish

Jim Cramer Wants Novo Nordisk A/S (NYSE:NVO) To Compete With Eli Lilly In The Market & Not The Courts

finance.yahoo.com·Jul 25, 2026·Novo Nordisk A/S (NYSE:NVO) was at the center of media coverage as it sued rival weight loss drug manufacturer Eli Lilly on Tuesday. The firm claimed that Lilly...